Keywords: Dementia, Blood vesselsSmall vessel disease (SVD) related vascular contributions to cognitive impairment and dementia (VCID) represent a major factor in cognitive decline in older adults. However, there has not been a validated biomarker for the diagnosis and treatment monitoring of this condition. Recently, the US National Institute on Neurological Disorders and Stroke (NINDS), a branch of NIH, funded a MarkVCID consortium, the goal of which is to identify and validate clinical-trial-ready biomarkers for VCID. Cerebrovascular reactivity (CVR) MRI was one of the selected biomarkers that underwent multi-site testing. The present work reports the relationship between CVR and cognitive function, and examines whether the pre-specified hypothesis can be reproduced at each of the sites.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords